Jakob Haldor Topsoe - May 12, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director, 10%+ Owner
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
May 12, 2022
Transactions value $
$233,674
Form type
4
Date filed
5/16/2022, 05:22 PM
Previous filing
Apr 5, 2022
Next filing
May 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Purchase $117K +8.25K +14.77% $14.17 64.1K May 12, 2022 Direct F1
transaction IGMS Common Stock Purchase $117K +7.85K +12.24% $14.86 72K May 13, 2022 Direct F2
holding IGMS Common Stock 10.4M May 12, 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $13.95 to $14.546615. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
F2 This transaction was executed in multiple trades at prices ranging from $14.70 to $15.00. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
F3 The shares are held directly by Topsoe Holding A/S (formerly Haldor Topsoe Holding A/S). Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.